首页> 美国卫生研究院文献>British Medical Journal >Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial
【2h】

Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial

机译:英国初级保健(CADET)中合作治疗抑郁症的临床效果:分组随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objective To compare the clinical effectiveness of collaborative care with usual care in the management of patients with moderate to severe depression.>Design Cluster randomised controlled trial.>Setting 51 primary care practices in three primary care districts in the United Kingdom.>Participants 581 adults aged 18 years and older who met ICD-10 (international classification of diseases, 10th revision) criteria for a depressive episode on the revised Clinical Interview Schedule. We excluded acutely suicidal patients and those with psychosis, or with type I or type II bipolar disorder; patients whose low mood was associated with bereavement or whose primary presenting problem was alcohol or drug abuse; and patients receiving psychological treatment for their depression by specialist mental health services. We identified potentially eligible participants by searching computerised case records in general practices for patients with depression.>Interventions Collaborative care, including depression education, drug management, behavioural activation, relapse prevention, and primary care liaison, was delivered by care managers. Collaborative care involved six to 12 contacts with participants over 14 weeks, supervised by mental health specialists. Usual care was family doctors’ standard clinical practice. >Main outcome measures Depression symptoms (patient health questionnaire 9; PHQ-9), anxiety (generalised anxiety disorder 7; GAD-7), and quality of life (short form 36 questionnaire; SF-36) at four and 12 months; satisfaction with service quality (client satisfaction questionnaire; CSQ-8) at four months.>Results 276 participants were allocated to collaborative care and 305 allocated to usual care. At four months, mean depression score was 11.1 (standard deviation 7.3) for the collaborative care group and 12.7 (6.8) for the usual care group. After adjustment for baseline depression, mean depression score was 1.33 PHQ-9 points lower (95% confidence interval 0.35 to 2.31, P=0.009) in participants receiving collaborative care than in those receiving usual care at four months, and 1.36 points lower (0.07 to 2.64, P=0.04) at 12 months. Quality of mental health but not physical health was significantly better for collaborative care than for usual care at four months, but not 12 months. Anxiety did not differ between groups. Participants receiving collaborative care were significantly more satisfied with treatment than those receiving usual care. The number needed to treat for one patient to drop below the accepted diagnostic threshold for depression on the PHQ-9 was 8.4 immediately after treatment, and 6.5 at 12 months.>Conclusions Collaborative care has persistent positive effects up to 12 months after initiation of the intervention and is preferred by patients over usual care.>Trial registration number ISRCTN32829227.
机译:>目的比较合作医疗与常规医疗在中度至重度抑郁症患者管理中的临床效果。>设计整群随机对照试验。>设置英国三个主要护理地区的51种初级护理实践。>参与者 581名18岁及以上的成年人符合ICD-10(国际疾病分类,第10版)的抑郁发作标准修订后的临床面试时间表。我们排除了急性自杀患者和患有精神病或I型或II型双相情感障碍的患者;情绪低落与丧亲相关或主要表现为饮酒或滥用药物的患者;以及通过专业心理健康服务为抑郁症接受心理治疗的患者。我们通过搜索一般的抑郁症患者计算机病例记录来确定潜在合格的参与者。>干预:协作治疗包括抑郁症教育,药物管理,行为激活,预防复发和初级保健联络护理经理。在心理健康专家的监督下,合作医疗在14周内与参与者进行了6至12次接触。通常的护理是家庭医生的标准临床做法。 >主要结局指标抑郁症状(患者健康调查问卷9; PHQ-9),焦虑症(一般性焦虑症7; GAD-7)和生活质量(简短表格36问卷; SF-36) 4个月和12个月;在四个月的时间里对服务质量的满意度(客户满意度问卷; CSQ-8)。>结果将276名参与者分配给合作医疗,而305名参与者分配给常规医疗。在四个月时,合作医疗组的平均抑郁评分为11.1(标准差7.3),而普通护理组的平均抑郁评分为12.7(6.8)。调整基线抑郁后,接受协作治疗的参与者的平均抑郁得分比接受常规治疗的参与者低1.33 PHQ-9点(95%置信区间0.35至2.31,P = 0.009),比接受常规治疗的参与者低1.336点(0.07)至2.64,P = 0.04)在12个月时。在四个月而非十二个月时,合作医疗的心理健康质量而非身体健康显着好于常规护理。两组之间的焦虑无异。接受合作治疗的参与者对治疗的满意度明显高于接受常规治疗的参与者。在治疗后立即使一名患者的PHQ-9下降到公认的抑郁症诊断阈值以下的人数为8.4,而在12个月时为6.5。>结论干预开始后12个月,患者优先于常规护理。>试验注册号 ISRCTN32829227。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号